Showing results (201-210 of 237) with videos related to
Sort By:
Pageof 24
American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.Cancer Research|October 15, 1994
Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group studyC J Fabian, B F Kimler, R McKittrick, et al.Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinomaD C Allred, G M Clark, A K Tandon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.Journal of Racial and Ethnic Health Disparities|January 28, 2026
Struggles, Strength, and Aspirations: Voices of Healthcare Workers in a Major Hospital SystemMohammad A Salameh, Jensen D Reckhow, Megan A Allyse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trialsK S Albain, S R Green, A S Lichter, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.Breast Cancer Research and Treatment|May 1, 1997
Cytological evaluation of biological prognostic markers from primary breast carcinomasA Makris, D C Allred, T J Powles, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigationsJ A Katzenellenbogen, R E Coleman, R A Hawkins, et al.Pageof 24